Geojit Financial Services has reaffirmed a BUY rating on Aurobindo Pharma Limited with a target price of Rs 1,540, implying a potential upside of 25% from the current market price of Rs 1,229.

Indian markets closed negative due to selling in banking and blue-chip stocks. Adani Group stocks pulled the indices down.

KRChoksey Research has issued a BUY recommendation for Aurobindo Pharma Ltd with a target price (TP) of Rs 1,591, suggesting a 25.6% potential upside from the current market price of Rs 1,267.

Prabhudas Lilladher has issued an Accumulate rating on Aurobindo Pharma Ltd. (ARBP), setting a target price of Rs 1,475.

Market expert Kushal Gupta has suggested four BUY Calls and one SELL Call for today’s trading session.

Market analyst Mitesh Thakkar has suggested three BUY Calls and one SELL Call for short term traders.